Artículos por temáticas

Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study

Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262(4):341-50. doi: 10.1007/s00406-011-0234-2. Epub 2011 Aug 5.

[Implementation of section 87b of the guidelines of SGB XI--the point-of-view of the nurses aides]

Eberhardt D, Sadowski K.

Pflege Z. 2012 Feb;65(2):90-5.

Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system

Perilli V, Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Cassano G, Cordiano N, Pinto K, Minervini MG, Oliva D.

Res Dev Disabil. 2012 Jul-Aug;33(4):1014-20. doi: 10.1016/j.ridd.2012.01.007. Epub 2012 Feb 21.

Intervention for several behavioural disorders in Alzheimer's-type dementia

Ogawa N, Hosomi J, Koura S, Oshikawa T, Tateishi N, Tanaka M, Kamijyo K, Tanigawa Y.

Psychogeriatrics. 2012 Jun;12(2):133-6. doi: 10.1111/j.1479-8301.2012.00420.x.

Relapse risk after discontinuation of risperidone in Alzheimer's disease

Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B.

N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058.

The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results

Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.

J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.

[Non pharmacological treatment for Alzheimer's disease: comparison between musical and non-musical interventions]

Narme P, Tonini A, Khatir F, Schiaratura L, Clément S, Samson S.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Jun;10(2):215-24. doi: 10.1684/pnv.2012.0343.

Behavioral and psychological symptoms in moderate to severe Alzheimer's disease: a palliative care approach emphasizing recognition of personhood and preservation of dignity

Passmore MJ, Ho A, Gallagher R.

J Alzheimers Dis. 2012;29(1):1-13. doi: 10.3233/JAD-2012-111424.

Solving the puzzle of Alzheimer disease

Uriri-Glover J, McCarthy M, Cesarotti E.

Nurse Pract. 2012 Sep 10;37(9):20-7; quiz 27-8. doi: 10.1097/01.NPR.0000418381.60864.68.

Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease

Christensen DD.

Postgrad Med. 2012 Nov;124(6):110-6. doi: 10.3810/pgm.2012.11.2589.

Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation

Trebbastoni A, Gilio F, D'Antonio F, Cambieri C, Ceccanti M, de Lena C, Inghilleri M.

Clin Neurophysiol. 2012 May;123(5):902-9. doi: 10.1016/j.clinph.2011.09.010. Epub 2011 Oct 12.

Selective liver X receptor modulators (SLiMs): what use in human health?

Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S.

Mol Cell Endocrinol. 2012 Apr 4;351(2):129-41. doi: 10.1016/j.mce.2011.08.036. Epub 2011 Sep 1.

[Efficacy, safety and tolerability of a single dose of akatinol memantine in comparison to two-doses in patients with moderately expressed and moderately severe dementia in Alzheimer's disease]

Kolykhalov IV, Gavrilova SI, Kalyn IaB, Selezneva ND, Fedorova IaB.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(1):35-9.

Neurosteroid PREGS protects neurite growth and survival of newborn neurons in the hippocampal dentate gyrus of APPswe/PS1dE9 mice

Xu B, Yang R, Chang F, Chen L, Xie G, Sokabe M, Chen L.

Curr Alzheimer Res. 2012 Mar;9(3):361-72. doi: 10.2174/156720512800107591.

Personality characteristics of staff in elderly care-a cross-cultural comparison

Richter J, Aström S, Isaksson U.

Issues Ment Health Nurs. 2012 Feb;33(2):96-100. doi: 10.3109/01612840.2011.624675.